Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
ADVERTISEMENT
ADVERTISEMENT
image name
Medicinal Chemistry

Slow and steady action makes brain cancer drug candidate more selective

Researchers designed a molecule that kills brain cancer cells while giving healthy cells time to repair their DNA


Radar Therapeutics launches for targeted treatments

RNA sensor technology switches on protein production only in specific cells

image name
Environment

Settlement reached in Ohio train derailment case

$310 million agreement would allow for long-term environmental and health monitoring but still contains gaps, critics say


BioBTX advances waste to aromatics

In the face of setbacks by others, the Dutch firm plans a commercial plant by 2026


Miniature polymeric tubes separate enantiomers

Devices could offer an alternative to chromatography and speed screening of chiral compounds